ABIGAIL HAMILTON: Open Payments
NPI 1790321693 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,219 in 131 payments from 19 companies in 2025. Trend: 2023 $3,454 · 2024 $3,196 · 2025 $3,219
Food & beverage: $3,149Education: $70
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $411 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $398 |
| Vanda Pharmaceuticals Inc. | 16 | $386 |
| ABBVIE INC. | 23 | $311 |
| Axsome Therapeutics, Inc. | 12 | $305 |
| Alkermes, Inc. | 11 | $283 |
| E.R. Squibb & Sons, L.L.C. | 5 | $214 |
| Otsuka America Pharmaceutical, Inc. | 10 | $199 |
| Janssen Pharmaceuticals, Inc | 7 | $194 |
| REVANCE THERAPEUTICS, INC. | 1 | $146 |
Products named: CAPLYTA, FANAPT, VRAYLAR, Auvelity, ARISTADA, COBENFY, REXULTI, UZEDY.
Industry payments across IL — which companies pay providers there.
